Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
Public ClinicalTrials.gov record NCT03619005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study (Placebo-Controlled, Double-Blind and Randomized Phase III Study of Intravaginal Prasterone)
Study identification
- NCT ID
- NCT03619005
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Placebo Vaginal Insert Drug
- Prasterone 6.5 mg (0.50%) Vaginal Insert Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2018
- Primary completion
- Aug 14, 2019
- Completion
- Dec 5, 2019
- Last update posted
- Jul 30, 2020
2018 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endoceutics site # 106 | Huntsville | Alabama | 35801 | — |
| Endoceutics site # 17 | San Diego | California | 92120 | — |
| Endoceutics site # 125 | New London | Connecticut | 06320 | — |
| Endoceutics site # 114 | St. Petersburg | Florida | 33709 | — |
| Endoceutics site # 119 | Roswell | Georgia | 30075 | — |
| Endoceutics site # 91 | Savannah | Georgia | 31406 | — |
| Endoceutics site # 20 | New York | New York | 10016 | — |
| Endoceutics site # 115 | Fargo | North Dakota | 58103 | — |
| Endoceutics site # 127 | Bluffton | South Carolina | 29910 | — |
| Endoceutics site # 102 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03619005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03619005 live on ClinicalTrials.gov.